Drug
Cepheid Poc Hcv Viremia Test
Cepheid Poc Hcv Viremia Test: highest development phase Post-Market, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cepheid POC HCV Viremia (RNA) test NCT05582681 | Post-Market | Hepatitis C |
Latest
No recent events.
Follow Cepheid Poc Hcv Viremia Test on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.